Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 6/20 | 0.51 |
| ▸ | CETP | P11597 | 4/20 | 0.48 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4610697 | 0.94 | FAAH (0.47) | FAAHTSHR | |
| SCHEMBL1563400 | 0.81 | NR1I2 (0.51) | ALDH1A1 | |
| SCHEMBL18177969 | 0.78 | CYP2C9 (0.39) | TSHRALDH1A1 | |
| SCHEMBL482725 | 0.76 | LPAR3 (0.51) | CETPALDH1A1 | |
| SCHEMBL11313574 | 0.76 | LPAR3 (0.51) | CETPALDH1A1 | |
| SCHEMBL18139230 | 0.76 | LPAR3 (0.51) | CETPALDH1A1 | |
| SCHEMBL18140785 | 0.76 | LPAR3 (0.51) | CETPALDH1A1 | |
| SCHEMBL1100818 | 0.76 | LPAR3 (0.51) | CETPALDH1A1 | |
| SCHEMBL1100962 | 0.76 | LPAR3 (0.51) | CETPALDH1A1 | |
| SCHEMBL8656282 | 0.76 | LPAR3 (0.51) | CETPALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10374256-B2 | Nonaqueous electrolyte solution, electricity storage device using same, and phosphonoformic acid compound used in same | UBE INDUSTRIES, LTD. (JP) | 2019-08-06 | — | — | US | disclosed |
| US-20160315351-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, ELECTRICITY STORAGE DEVICE USING SAME, AND PHOSPHONOFORMIC ACID COMPOUND USED IN SAME | UBE INDUSTRIES, LTD (JP) | 2016-10-27 | — | — | US | disclosed |
| US-20160315351-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, ELECTRICITY STORAGE DEVICE USING SAME, AND PHOSPHONOFORMIC ACID COMPOUND USED IN SAME | UBE INDUSTRIES, LTD (JP) | 2016-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10374256-B2 | Nonaqueous electrolyte solution, electricity storage device using same, and phosphonoformic acid compound used in same | HCN2, PHOSPHO1, HCN1 | FAAH 1458/4885CETP 3476/4885ZDHHC2 3124/4885 |
| US-20160315351-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, ELECTRICITY STORAGE DEVICE USING SAME, AND PHOSPHONOFORMIC ACID COMPOUND USED IN SAME | HCN2, PHOSPHO1, HCN1 | FAAH 1458/4885CETP 3476/4885ZDHHC2 3124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.